Ken Griffin Evotec Se Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Evotec Se stock. As of the latest transaction made, Citadel Advisors LLC holds 27,460 shares of EVO stock, worth $145,538. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,460
Previous 11,444
139.95%
Holding current value
$145,538
Previous $54,000
85.19%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EVO
# of Institutions
25Shares Held
3.42MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA2.63MShares$14 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT217KShares$1.15 Million0.33% of portfolio
-
Mediolanum International Funds LTD Dublin 1, L2140KShares$744,0290.01% of portfolio
-
Morgan Stanley New York, NY122KShares$649,0060.0% of portfolio
-
Black Rock Inc. New York, NY82.6KShares$437,7690.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.88B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...